Log In
Print
BCIQ
Print
Print this Print this
 

Sprycel, dasatinib

Also known as: BMS-354825

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionSmall molecule inhibitor of BCR-ABL and Src kinases
Molecular Target BCR-ABL tyrosine kinase ; Src
Mechanism of ActionKinase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today